Immunogenicity and Safety of a Chemically Synthesized Divalent Group A Streptococcal Vaccine
Background. Group A streptococcus (GAS) infections and poststreptococcal sequelae remain a health problem worldwide, which necessitates searching for an effective vaccine, while no licensed GAS vaccine is available. We have developed a divalent peptide vaccine composed of 84 amino acids to cover the...
Na minha lista:
| Principais autores: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wiley
2018-01-01
|
| coleção: | Canadian Journal of Infectious Diseases and Medical Microbiology |
| Acesso em linha: | http://dx.doi.org/10.1155/2018/4702152 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|